Loading stock data…
Addus HomeCare Corporation (ADUS)
$119.32+0.56 (+0.47%)
After Hours$119.32+0.00 (+0.00%)· Last close Sep 8
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Addus HomeCare Corporation in the Healthcare sector is trading at $119.32 with a market capitalization of $2.2B. Wall Street consensus targets $134.69 (13 analysts), implying a +12.9% move over the next 12 months. The stock is currently near its 52-week high of $124.44, remaining 12.9% above its 200-day moving average. On fundamentals, Piotroski 7/9 indicates strong financial quality, Altman Z in the safe zone. The Whystock Score of 100/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +12.9% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $377.42M↑ | $363.61M↓ | $373.08M↑ | $362.30M↑ | $349.44M |
| Gross Profit | $121.56M↑ | $115.87M↓ | $123.61M↑ | $116.72M↑ | $113.88M |
| Operating Income | $38.94M↑ | $34.07M↓ | $42.28M↑ | $32.94M↑ | $32.89M |
| Net Income | $27.61M↑ | $25.07M↓ | $29.78M↑ | $22.85M↑ | $22.05M |
Peer Comparison
JNJUNHPFE
Fundamentals
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company op...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$2.22B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
20.71
Beta
Defensive asset. Lower volatility than the S&P 500.
0.86
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
9.17%
Volume
Today's trading volume
142,616
Recent News
Can BTSG Outgrow the $20B Acute Infusion Market on Volume Growth?
BrightSpring Health Services is gaining acute infusion share with 20%+ volume growth, targeting 12-15 new states in a $20 billion market.
1 Growth Stock to Stash and 2 We Turn Down
Growth is a hallmark of all great companies, but the laws of gravity eventually take hold. Those who rode the COVID boom and ensuing tech selloff in 2022 will surely remember that the market’s punishment can be swift and severe when trajectories fall.
Market Shocks Are Not Where Hims & Hers Health Stock Has Fallen Furthest
Its deepest fall inside a market shock is not its deepest fall, and that gap is what a holder should size for.
Is Addus HomeCare (ADUS) Undervalued After Its Q2 Earnings Beat?
Addus HomeCare Q2 results and what they mean for the stock Addus HomeCare (ADUS) drew attention after reporting Q2 2026 results that showed revenue in line with expectations alongside an earnings per share beat. For investors, that mix raises fresh questions about how the stock reflects its fundamentals. The share price of Addus HomeCare has eased slightly in the short term, with the 1-day, 7-day and 30-day share price returns all down modestly, even after a strong 90-day share price return...
Addus HomeCare (ADUS) Stock Looks Cheap Relative To Fair Value
Addus HomeCare stock has delivered a 34.6% gain over the past three years, while a fresh intrinsic value estimate suggests the current price may still sit below what its future cash flows imply. The market price near US$118 puts investors between a strong historical return and an analytical view that points to possible undervaluation. A 34.6% share price gain over three years shows that Addus HomeCare has already rewarded patient investors, so the question is how much of the long term...